Inventor · disambiguated record
Matthew Marton
Also filed as: MARTON MATTHEW · MARTON MATTHEW J
7 granted patents·4 pending applications·161 citations·filing 1998–2022
84Inventor score
Files withMERCK SHARP & DOHME4ROSETTA INPHARMATICS LLC2AGILENT TECHNOLOGIES INC1KRONICK MEL N1MARTON MATTHEW1
Top patents by PatentIndex Score
11 records- 0192US6222093B1Methods for determining therapeutic index from gene expression profilesROSETTA INPHARMATICS INC·Filed 1998·Granted Apr 24, 2001·128 cites·45 claims
- 0286US7569343B2Methods to assess quality of microarraysROSETTA INPHARMATICS LLC·Filed 2003·Granted Aug 4, 2009·19 cites·18 claims
- 0379US11364243B2Methods for treating cancer with a WEE1 inhibitorMERCK SHARP & DOHME·Filed 2019·Granted Jun 21, 2022·1 cites·16 claims
- 0470US7642097B2Manufacture and use of non-standard size microarray slidesAGILENT TECHNOLOGIES INC·Filed 2008·Granted Jan 5, 2010·5 cites·14 claims
- 0569US10053737B2Methods and compositions for treating cancer by identifying one or more ERK mutationsMERCK SHARP & DOHME·Filed 2014·Granted Aug 21, 2018·1 cites·15 claims
- 0668US2023083689A1Methods for treating cancer with a wee1 inhibitorMERCK SHARP & DOHME·Filed 2022·Application pending·0 cites
- 0763US7254487B2Methods for determining therapeutic index from gene expression profilesROSETTA INPHARMATICS LLC·Filed 2001·Granted Aug 7, 2007·7 cites·35 claims
- 0862US8560243B2Methods for determining therapeutic index from gene expression profilesMARTON MATTHEW·Filed 2007·Granted Oct 15, 2013·0 cites·19 claims
- 0951US2002146694A1Functionating genomes with cross-species coregulationFiled 2001·Application pending·0 cites
- 1042US2017095479A1Methods for Treating Cancer with a WEE1 InhibitorMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 1139US2006141507A1Manufacture and use of non-standard size microarray slidesKRONICK MEL N·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →